VAERS reports by lot

Moderna COVID-19 lot 037821A: VAERS reports

27 VAERS reports list lot 037821A as a Moderna COVID-19 vaccine, received between 2021-04-09 and 2023-02-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
15%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5231%
Musculoskeletal2515%
Neurological2414%
Gastrointestinal1710%
Cardiac / Cardiovascular169%
Respiratory95%
Injection-site / Local reaction95%
Dermatological (non-injection-site)74%
Allergic / Anaphylactic53%
Thrombotic / Hematological42%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Indiana4
Maryland3
Massachusetts2
Kentucky2
Ohio1
New York1
Georgia1
Connecticut1
Tennessee1
Virginia1
New Jersey1

Reports by month received

2021-049
2021-052
2021-073
2021-085
2021-092
2021-102
2022-031
2022-041
2022-081
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.